Prevalence and treatment outcomes of skin infections among elderly population: a retrospective cross-sectional study

References

• Jafferany M, Huynh TV, Silverman MA, et al. Geriatric dermatoses: a clinical review of skin diseases in an aging population. Int J Dermatol. 2012;51(5):509–522.
   PubMed Web of Science ®Google Scholar
• Farage MA, Miller KW, Berardesca E, et al. Clinical implications of aging skin. Am J Clin Dermatol. 2009;10(2):73–86.
   PubMed Web of Science ®Google Scholar
• Mponda K, Masenga J. Skin diseases among elderly patients attending skin clinic at the regional dermatology training Centre, Northern Tanzania: a cross-sectional study. BMC Res Notes. 2016;9(1):119.
   PubMedGoogle Scholar
• Winker MA. Aging in the 21st century: a call for papers. JAMA. 2002;287(10):1326.
   PubMed Web of Science ®Google Scholar
• Yalçın B, Tamer E, Toy GG, et al. The prevalence of skin diseases in the elderly: analysis of 4099 geriatric patients. Int J Dermatol. 2006;45(6):672–676.
   PubMed Web of Science ®Google Scholar
• Fenske NA, Lober CW. Skin changes of aging: pathological implications. Geriatrics. 1990;45(3):27–35.
   PubMed Web of Science ®Google Scholar
• Pallin DJ, Espinola JA, Leung DY, et al. Epidemiology of dermatitis and skin infections in United States physicians’ offices, 1993–2005. Clin Infect Dis. 2009;49(6):901–907.
   PubMed Web of Science ®Google Scholar
• Edelsberg J, Taneja C, Zervos M, et al. Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis. 2009;15(9):1516–1518.
   PubMed Web of Science ®Google Scholar
• Pallin DJ, Egan DJ, Pelletier AJ, et al. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med. 2008;51(3):291–298.
   PubMed Web of Science ®Google Scholar
• Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):e10–e52.
   PubMed Web of Science ®Google Scholar
• Rollason V, Vogt N. Reduction of polypharmacy in the elderly. Drugs Aging. 2003;20(11):817–832.
   PubMed Web of Science ®Google Scholar
• Mansur N, Weiss A, Beloosesky Y. Looking beyond polypharmacy: quantification of medication regimen complexity in the elderly. Am J Geriatr Pharmacother. 2012;10(4):223–229.
   PubMedGoogle Scholar
• George J, Phun Y-T, Bailey MJ, et al. Development and validation of the medication regimen complexity index. Ann Pharmacother. 2004;38(9):1369–1376.
   PubMed Web of Science ®Google Scholar
• Stone VE, Hogan JW, Schuman P, et al. Antiretroviral regimen complexity, self-reported adherence, and HIV patients’ understanding of their regimens: survey of women in the her study. J Acquir Immune Defic Syndr. 2001;28(2):124–131.
   PubMed Web of Science ®Google Scholar
• Melchiors AC, Correr CJ, Fernández-Llimos F. Translation and validation into Portuguese language of the medication regimen complexity index. Arq Bras Cardiol. 2007;89(4):210–218.
   PubMed Web of Science ®Google Scholar
• Bushardt RL, Massey EB, Simpson TW, et al. Polypharmacy: misleading, but manageable. Clin Interv Aging. 2008;3(2):383–389.
   PubMed Web of Science ®Google Scholar
• Kalache A. Active ageing makes the difference. Curr Opin Psychiatry. 1999;12(4):449–450.
   Web of Science ®Google Scholar
• Beauregard S, Gilchrest BA. A survey of skin problems and skin care regimens in the elderly. Arch Dermatol. 1987;123(12):1638–1643.
   PubMedGoogle Scholar
• Adam JE, Reilly S. The prevalence of skin disease in the geriatric age group. Australas J Dermatol. 1987;28(2):72–76.
   PubMedGoogle Scholar
• Aisen E, Shafran A, Gilhar A. Sebum and water content in the skin of aged immobilized patients. Acta Derm Venereol. 1997;77(2):142–143.
   PubMed Web of Science ®Google Scholar
• Linjakumpu T, Hartikainen S, Klaukka T, et al. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol. 2002;55(8):809–817.
   PubMed Web of Science ®Google Scholar
• Lucchetti G, Granero AL, Pires SL, et al. Factors associated to polypharmacy in institutionalized elderly. Rev Bras Geriatr Gerontol. 2010;13(1):51–58.
   Google Scholar
• Silva R, Schmidt O, Silva S. Polypharmacy in geriatrics. Rev da AMRIGS. 2012;56(2):164–174.
   Google Scholar
• Wimmer BC, Dent E, Visvanathan R, et al. Polypharmacy and medication regimen complexity as factors associated with hospital discharge destination among older people: a prospective cohort study. Drugs Aging. 2014;31(8):623–630.
   PubMed Web of Science ®Google Scholar
• Benetos A, Rossignol P, Cherubini A, et al. Polypharmacy in the aging patient: management of hypertension in octogenarians. JAMA. 2015;314(2):170–180.
   PubMed Web of Science ®Google Scholar
• Acurcio FA, Silva ALd, Ribeiro AQ, et al. Complexity of therapeutic regimens prescribed for elderly retirees, Belo Horizonte/MG, Brazil. Rev Assoc Med Bras. 2009;55(4):468–474.
   PubMed Web of Science ®Google Scholar
• Advinha AM, de Oliveira-Martins S, Mateus V, et al. Medication regimen complexity in institutionalized elderly people in an aging society. Int J Clin Pharm. 2014;36(4):750–756.
   PubMed Web of Science ®Google Scholar
• Wimmer BC, Johnell K, Fastbom J, et al. Factors associated with medication regimen complexity in older people: a cross-sectional population-based study. Eur J Clin Pharmacol. 2015;71(9):1099–1108.
   PubMed Web of Science ®Google Scholar
• Gorzoni ML, Fabbri RMA, Pires SL. Potentially inappropriate medications in elderly. Rev Assoc Méd Brasil. 2012;58(4):442–446.
   PubMed Web of Science ®Google Scholar
• Mendes-Netto RS, Silva CQ, Oliveira Filho AD, et al. Assessment of drug interactions in elderly patients of a family health care unit in Aracaju (Brazil): a pilot study. Afr J Pharm Pharmacol. 2011;5(7):812–818.
   Google Scholar
• Higgins E, Vivier A. Cutaneous disease and alcohol misuse. Br Med Bull. 1994;50(1):85–98.
   PubMed Web of Science ®Google Scholar
• Poikolainen K, Reunala T, Karvonen J, et al. Alcohol intake: a risk factor for psoriasis in young and middle aged men? BMJ. 1990;300(6727):780–783.
   PubMedGoogle Scholar
• Qureshi AA, Dominguez PL, Choi HK, et al. Alcohol intake and risk of incident psoriasis in US women: a prospective study. Arch Dermatol. 2010;146(12):1364–1369.
   PubMedGoogle Scholar
• Kazakevich N, Moody MN, Landau JM, et al. Alcohol and skin disorders: with a focus on psoriasis. Skin Ther Lett. 2011;16(4):5–6.
   PubMedGoogle Scholar
• Smith KE, Fenske NA. Cutaneous manifestations of alcohol abuse. J Am Acad Dermatol. 2000;43(1):1–18.
   PubMed Web of Science ®Google Scholar
• Gupta MA, Schork NJ, Gupta AK, et al. Alcohol intake and treatment responsiveness of psoriasis: a prospective study. J Am Acad Dermatol. 1993;28(5):730–732.
   PubMed Web of Science ®Google Scholar
• Armstrong AW, Lin SW, Chambers CJ, et al. Psoriasis and hypertension severity: results from a case-control study. PLoS One. 2011;6(3):e18227.
   PubMed Web of Science ®Google Scholar
• Takeshita J, Wang S, Shin DB, et al. Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom. JAMA Dermatol. 2015;151(2):161–169.
   PubMed Web of Science ®Google Scholar
• Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. JAMA Dermatol. 2013;149(1):84–91.
   PubMed Web of Science ®Google Scholar
• Armstrong AW, Guérin A, Sundaram M, et al. Psoriasis and risk of diabetes-associated microvascular and macrovascular complications. J Am Acad Dermatol. 2015;72(6):968–977. e2.
   PubMed Web of Science ®Google Scholar
• Ma C, Harskamp C, Armstrong E, et al. The association between psoriasis and dyslipidaemia: a systematic review. Br J Dermatol. 2013;168(3):486–495.
   PubMed Web of Science ®Google Scholar
• Mehta NN, Li R, Krishnamoorthy P, et al. Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis. Atherosclerosis. 2012;224(1):218–221.
   PubMed Web of Science ®Google Scholar
• Holzer M, Wolf P, Curcic S, et al. Psoriasis alters HDL composition and cholesterol efflux capacity. J Lipid Res. 2012;53(8):1618–1624.
   PubMed Web of Science ®Google Scholar
• Salahuddin T, Natarajan B, Playford MP, et al. Cholesterol efflux capacity in humans with psoriasis is inversely related to non-calcified burden of coronary atherosclerosis. Eur Heart J. 2015;36(39):2662–2665.
   PubMed Web of Science ®Google Scholar